Regulatable and cell-type specific transgene expression in glial cells: prospects for gene therapy for neurological disorders
- 1 January 2001
- book chapter
- Published by Elsevier
- Vol. 132, 655-681
- https://doi.org/10.1016/s0079-6123(01)32109-x
Abstract
No abstract availableThis publication has 129 references indexed in Scilit:
- Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's DiseaseHuman Gene Therapy, 2000
- Efficient gene transfer and long-term expression in neurons using a recombinant adenovirus with a neuron-specific promoterGene Therapy, 1999
- Steroid Hormone-Inducible Expression of the GLT-1 Subtype of High-Affinity l-Glutamate Transporter in Human Embryonic Kidney CellsBiochemical and Biophysical Research Communications, 1999
- Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infectionGene Therapy, 1999
- Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analoguesGene Therapy, 1997
- Adenovirus-Mediated Inducible Gene Expression through Tetracycline-Controllable Transactivator with Nuclear Localization SignalBiochemical and Biophysical Research Communications, 1997
- Control of Memory Formation Through Regulated Expression of a CaMKII TransgeneScience, 1996
- Immune responses to adenovirus vectors in the nervous systemTrends in Neurosciences, 1996
- Transduction of foreign regulatory sequences by a replication-defective herpes simplex virus type 1: The rat neuron-specific enolase promoterVirus Research, 1995
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991